BioAge Labs, Inc.
BIOA
$4.13
-$0.07-1.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.49% | -0.82% | -60.05% | 20.98% | -17.21% |
| Total Depreciation and Amortization | 12.12% | 14.63% | -20.83% | 22.50% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 54.00% | -70.05% | -60.04% | -64.95% | 42.44% |
| Change in Net Operating Assets | -60.26% | 199.96% | 382.65% | -418.53% | -1,262.32% |
| Cash from Operations | -10.79% | 39.57% | -92.34% | -42.24% | -56.70% |
| Capital Expenditure | -- | -- | -208.08% | 37.50% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -208.08% | 37.50% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -50.00% | -- | -- | -- |
| Issuance of Common Stock | -- | 691,050.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -9,469.23% | -5,950.00% | -31,625.00% | -12,450.00% |
| Cash from Financing | -100.89% | 2,567.99% | 454,107.14% | -119.10% | 615.02% |
| Foreign Exchange rate Adjustments | -163.16% | 310.77% | -265.71% | -140.48% | 258.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -163.58% | 307.53% | 2,328.86% | -1,413.63% | 1,039.31% |